Teduglutide in amyloidosis-associated intestinal failure.

Luhn, Clara; Agis, Hermine; Hütterer, Elisabeth; Simonitsch-Klupp, Ingrid; Dawoud, Christopher; Stift, Anton; Harpain, Felix

Luhn, Clara; Agis, Hermine; Hütterer, Elisabeth; Simonitsch-Klupp, Ingrid; Dawoud, Christopher; Stift, Anton; Harpain, Felix.

Afiliação

Luhn C; Division of Visceral Surgery, Department of General Surgery Medical University Vienna Vienna Austria.
Agis H; Division of Hematology and Hemostaseology, Department of Internal Medicine I Medical University of Vienna Vienna Austria.
Hütterer E; Division of Oncology, Department of Internal Medicine I Medical University of Vienna Vienna Austria.
Simonitsch-Klupp I; Department of Pathology Medical University of Vienna Vienna Austria.
Dawoud C; Division of Visceral Surgery, Department of General Surgery Medical University Vienna Vienna Austria.
Stift A; Division of Visceral Surgery, Department of General Surgery Medical University Vienna Vienna Austria.
Harpain F; Division of Visceral Surgery, Department of General Surgery Medical University Vienna Vienna Austria.

Clin Case Rep ; 11(8): e7653, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37601424

Palavras-chave

amyloidosis; enteral autonomy; glucagonlike peptide2; intestinal failure; teduglutide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Clin Case Rep Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google